World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 139 1725 1600 987 904 938 94265

Gary H. Lyman publications per year

The chart shows the history of publications by Gary H. Lyman between 1975 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Gary H. Lyman published across 51 years, from 1975 to 2025, averaging 19.5 papers a year. Output peaked at 56 publications in 2017. 23 of the 997 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1975 to 2025. Vertical axis: number of publications, 0 to 56. Peak 56 publications in 2017. 1975: 1 publication 1976: 3 publications 1977: 1 publication 1978: 3 publications 1979: 0 publications 1980: 3 publications 1981: 2 publications 1982: 1 publication 1983: 0 publications 1984: 2 publications 1985: 2 publications 1986: 9 publications 1987: 4 publications 1988: 6 publications 1989: 4 publications 1990: 5 publications 1991: 9 publications 1992: 5 publications 1993: 7 publications 1994: 10 publications 1995: 6 publications 1996: 10 publications 1997: 13 publications 1998: 15 publications 1999: 6 publications 2000: 18 publications 2001: 9 publications 2002: 10 publications 2003: 19 publications 2004: 46 publications 2005: 33 publications 2006: 33 publications 2007: 38 publications 2008: 38 publications 2009: 40 publications 2010: 36 publications 2011: 44 publications 2012: 40 publications 2013: 38 publications 2014: 33 publications 2015: 35 publications 2016: 42 publications 2017: 56 publications 2018: 40 publications 2019: 38 publications 2020: 50 publications 2021: 38 publications 2022: 27 publications 2023: 46 publications 2024: 13 publications 2025: 10 publications
1975 2025

997 publications in total across all disciplines

View publications per year as a table
Gary H. Lyman: publications per year, 1975 to 2025
Year Publications
1975 1
1976 3
1977 1
1978 3
1979 0
1980 3
1981 2
1982 1
1983 0
1984 2
1985 2
1986 9
1987 4
1988 6
1989 4
1990 5
1991 9
1992 5
1993 7
1994 10
1995 6
1996 10
1997 13
1998 15
1999 6
2000 18
2001 9
2002 10
2003 19
2004 46
2005 33
2006 33
2007 38
2008 38
2009 40
2010 36
2011 44
2012 40
2013 38
2014 33
2015 35
2016 42
2017 56
2018 40
2019 38
2020 50
2021 38
2022 27
2023 46
2024 13
2025 10
Total 997
Download as CSV

Gary H. Lyman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gary H. Lyman sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 921–940 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 938 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116 938
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Gary H. Lyman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gary H. Lyman sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 138–139 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 139 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134 139
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Gary H. Lyman is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research spans primarily the field of Medicine, with a particular focus on Oncology, alongside Economics and Econometrics, Public Health, Environmental and Occupational Health, Infectious Diseases, and Internal Medicine.

The scientist has contributed to several key topics in cancer and healthcare research including:

  • COVID-19 and healthcare impacts
  • Neutropenia and Cancer Infections
  • Economic and Financial Impacts of Cancer
  • Health Systems, Economic Evaluations, Quality of Life
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 Clinical Research Studies
  • Cancer Treatment and Pharmacology

Frequent coauthors collaborating with Gary H. Lyman include Nicole M. Kuderer, Petros Grivas, Jeremy L. Warner, Aakash Desai, and Dimpy P. Shah. These repeated partnerships reflect ongoing research efforts in cancer and related clinical studies.

Their work has been published in various scientific venues with most contributions found in Cancer Investigation, Journal of Clinical Oncology, Blood, Cancer Research, and UNC Libraries. These journals host a significant number of their publications, reflecting a continuous engagement with advancing oncology and clinical research.

Selected notable publications authored or coauthored by Gary H. Lyman include:

  • "Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study," 2020, The Lancet
  • "American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer," 2021, Blood Advances
  • "Antiemetics: ASCO Guideline Update," 2020, Journal of Clinical Oncology
  • "Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium," 2021, Annals of Oncology
  • "Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline," 2022, Journal of Clinical Oncology

The research output of Gary H. Lyman has contributed extensively to understanding the interface of cancer treatment with infectious diseases, particularly in the context of the COVID-19 pandemic. Their work also addresses venous thromboembolism management and integrates clinical guidelines to support treatment decisions in oncology settings.

Best Publications

  • Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

    Charles M. Balch;Seng-Jaw Soong;Jeffrey E. Gershenwald;John F. Thompson

  • American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

    Carolyn D. Runowicz;Corinne R. Leach;N. Lynn Henry;Karen S. Henry

  • American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

    Gary H. Lyman;Armando E. Giuliano;Mark R. Somerfield;Al B. Benson

  • Development and validation of a predictive model for chemotherapy-associated thrombosis

    Alok A. Khorana;Nicole M. Kuderer;Eva Culakova;Gary H. Lyman

  • Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

    Alok A. Khorana;C. W. Francis;E. Culakova;N. M. Kuderer

  • Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

    Jeffrey Crawford;Howard Ozer;Ronald Stoller;David H Johnson

  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

    Nicole M. Kuderer;Toni K. Choueiri;Dimpy P. Shah;Yu Shyr

  • Lymphatic mapping and sentinel node biopsy in the patient with breast cancer

    John J. Albertini;Gary H. Lyman;Charles Cox;Tim Yeatman

  • 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

    Thomas J. Smith;James Khatcheressian;Gary H. Lyman;Howard Ozer

  • American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

    Gary H. Lyman;Alok A. Khorana;Anna Falanga;Daniel Clarke-Pearson

  • Recommendations on the Use of 18F-FDG PET in Oncology

    James W. Fletcher;James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel

  • Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

    Annie M. Young;Andrea Marshall;Jenny Thirlwall;Oliver Chapman

  • Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

    Gary H. Lyman;Gary H. Lyman;Kari Bohlke;Alok A. Khorana;Nicole M. Kuderer

  • 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

    M. S. Aapro;J. Bohlius;David Cameron;Lissandra Dal Lago

  • Comorbidity and functional status are independent in older cancer patients.

    Martine Extermann;Janine Overcash;Gary H. Lyman;Joyce Parr

  • Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Gary H. Lyman;Sarah Temin;Stephen B. Edge;Lisa A. Newman

  • Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score

    Martine Extermann;Ivette Boler;Richard R. Reich;Richard R. Reich;Gary H. Lyman

  • Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

    Paul J. Hesketh;Mark G. Kris;Ethan Martin Basch;Kari Bohlke

  • American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options

    Lowell E. Schnipper;Nancy E. Davidson;Dana S. Wollins;Courtney Tyne

Frequent Co-Authors

Jeffrey Crawford
Jeffrey Crawford Duke University
David C. Dale
David C. Dale University of Washington
Alok A. Khorana
Alok A. Khorana Cleveland Clinic
Scott D. Ramsey
Scott D. Ramsey Fred Hutchinson Cancer Research Center
Lodovico Balducci
Lodovico Balducci University of South Florida
Charles W. Francis
Charles W. Francis University of Rochester Medical Center
Douglas S. Reintgen
Douglas S. Reintgen University of South Florida
Charles E. Cox
Charles E. Cox University of South Florida
Benjamin Djulbegovic
Benjamin Djulbegovic City Of Hope National Medical Center
Mark R. Somerfield
Mark R. Somerfield American Society of Clinical Oncology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to a variety of healthcare roles. Many students consider alternative or complementary online programs that offer flexibility and specialized knowledge. For example, those interested in preventative health may pursue an online BS in nutrition to gain expertise in dietetics and wellness.

The expanding field of health administration attracts students seeking leadership positions in hospitals or clinics. Accredited graduate programs, like online MHA programs CAHME accredited, are designed for future healthcare managers and can often be completed remotely.

Registered nurses aiming to advance their careers may ask, does RN to BSN require clinicals? Many online RN to BSN programs offer coursework that can be completed with few or no in-person clinical requirements, allowing for career growth without relocation.

For those pursuing the highest level of clinical nursing education, fastest online DNP programs provide an accelerated track to a Doctor of Nursing Practice, enabling nurses to move quickly into advanced practice, administration, or academia.

Best Scientists Citing Gary H. Lyman

Trending Scientists

Recently Published Articles